Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis

Yanina Ivashko-Pachima; Illana Gozes

doi:10.1007/s12031-020-01632-6

Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis

Yanina Ivashko-Pachima, Illana Gozes^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

7 Scopus citations

Original language	English
Pages (from-to)	993-998
Number of pages	6
Journal	Journal of Molecular Neuroscience
Volume	70
Issue number	7
DOIs	https://doi.org/10.1007/s12031-020-01632-6
State	Published - 1 Jul 2020

Funding

Funders	Funder number
APPD
Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease
AAMN Foundation
Tel Aviv University

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12031-020-01632-6

Cite this

@article{23e6399744fc4d5dadecf8e1038326cb,

title = "Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis",

author = "Yanina Ivashko-Pachima and Illana Gozes",

note = "Funding Information: Professor Gozes, Director of the Elton Laboratory for Molecular Neuroendocrinology work on this project is supported by the following grants, ERA-NET neuron ADNPinMED, AMN Foundation as well as Drs. Ronith and Armand Stemmer (French Friends of Tel Aviv University). Dr. Yanina Ivashko-Pachima is supported in part by the Aufzien Family Center for the Prevention and Treatment of Parkinson{\textquoteright}s Disease (APPD) postdoctoral fellowship and by a scholarship donated by Sandra Fischer, in the field of Alzheimer{\textquoteright}s research, in memory of Nettie and Manuel Fisher. ",

year = "2020",

month = jul,

day = "1",

doi = "10.1007/s12031-020-01632-6",

language = "אנגלית",

volume = "70",

pages = "993--998",

journal = "Journal of Molecular Neuroscience",

issn = "0895-8696",

publisher = "Springer",

number = "7",

}

TY - JOUR

T1 - Deciphering the Enigma

T2 - NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis

AU - Ivashko-Pachima, Yanina

AU - Gozes, Illana

N1 - Funding Information: Professor Gozes, Director of the Elton Laboratory for Molecular Neuroendocrinology work on this project is supported by the following grants, ERA-NET neuron ADNPinMED, AMN Foundation as well as Drs. Ronith and Armand Stemmer (French Friends of Tel Aviv University). Dr. Yanina Ivashko-Pachima is supported in part by the Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease (APPD) postdoctoral fellowship and by a scholarship donated by Sandra Fischer, in the field of Alzheimer’s research, in memory of Nettie and Manuel Fisher.

PY - 2020/7/1

Y1 - 2020/7/1

UR - http://www.scopus.com/inward/record.url?scp=85086856942&partnerID=8YFLogxK

U2 - 10.1007/s12031-020-01632-6

DO - 10.1007/s12031-020-01632-6

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 32588400

AN - SCOPUS:85086856942

SN - 0895-8696

VL - 70

SP - 993

EP - 998

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

IS - 7

ER -

Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis

Funding

UN SDGs

Access to Document

Other files and links

Cite this